No Carolina / NY / Florida
Ph: 561.316.3330

Varex Imaging Corporation Announces LUMEN 4336W Radiography Detector With IP68 Rating

Editor: What To Know

  • The LUMEN 4336W has an integrated inductive charger that allows wireless charging in a bucky, on a table-top, or in a carry case – wherever the detector may be between shots, reducing the need to remove the battery for charging.
  • The improvements in the LUMEN 4336W detector are coupled with the reliable image quality that Varex has built its reputation on.
  • The LUMEN 4336W joins the LUMEN 4343W as part of a new generation of detectors designed for increased durability and convenience for customers and end-users.

Varex Imaging Corporation (Nasdaq: VREX) today announced the addition of the LUMEN 4336W digital radiography detector to Varex’s product line. The LUMEN 4336W joins the LUMEN 4343W as part of a new generation of detectors designed for increased durability and convenience for customers and end-users.

The LUMEN 4336W includes the following features and benefits:

  • Robustness. The LUMEN 4336W has increased resistance to water ingress with an industry leading rating of IP68. This means that the LUMEN 4336W will be ready for real world use, from the physical challenges of the emergency department to the frequent disinfection cycles now demanded by changing standards of care.
  • Reliability. The LUMEN 4336W has been designed with reliability in mind. By simplifying the construction of the internal components, Varex has minimized potential points of failure while also improving the design of the housing to provide protection from external shocks.
  • Wireless Charging. The LUMEN 4336W has an integrated inductive charger that allows wireless charging in a bucky, on a table-top, or in a carry case – wherever the detector may be between shots, reducing the need to remove the battery for charging

The improvements in the LUMEN 4336W detector are coupled with the reliable image quality that Varex has built its reputation on. Varex’s expertise in high sensitivity, low noise designs means that these mechanical improvements can be matched with best in class image quality. For more information about the LUMEN 4336W, please contact your Varex representative or the individuals referenced below.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy